Novartis’ single pill combination of aliskiren and amlopidine – Tekamlo – has been approved by the Food and Drug Administration (FDA) for the treatment of hypertension. Data revealed that Tekamlo significantly reduced blood pressure compared to amlodipine or aliskiren (Tekturna) alone. The medication has been approved in tablet form.
Read full article at medical news today.
Related posts:
- Seven Influenza Vaccines For Coming Season Approved By FDA
- IFPMA approved for New Biopharmaceutical Strategy in Québec
- An update on Drug Interactions with Grapefruit Juice
- FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis
- FDA Again Warns Apotex Corp., a Generic Maker, About Conditions at Its Plants
Join hundreds of students and get all book resources for FREE! Subscribe to Pharmacy E-books via RSS or via E-mail
